Obesity is associated with increasing cardiometabolic morbidity and mortality rates
worldwide. Not everyone with obesity, however, develops metabolic complications. Brown …

Patatin-like phospholipase domain-containing protein 3 (PNPLA3) is a lipid droplet-
associated protein that has been shown to have hydrolase activity toward triglycerides and …

The prevalence of non-alcoholic fatty liver disease (NAFLD), one of the most common liver
diseases, is rising. About 25% of adults worldwide are probably affected by NAFLD. Insulin …

Objective To evaluate the cardiometabolic outcomes associated with discordant visceral
adipose tissue (VAT) and liver fat (LF) phenotypes in 2 cohorts. Patients and Methods …

The incidence of nonalcoholic fatty liver disease (NAFLD) has recently increased and is
related to obesity and the associated surge in type 2 diabetes mellitus (T2DM) and …

Background & Aims A causal association of non‐alcoholic fatty liver disease (NAFLD) with
cardiovascular disease (CVD) and type 2 diabetes (T2DM) remains unproved. We aimed to …

This clinical practice position statement, a product of the Fatty Liver Research Group of the
Korean Diabetes Association, proposes recommendations for the diagnosis, progression …

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease.
NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine …

As the rates of obesity and type 2 diabetes (T2D) continue to increase globally, so does the
prevalence of metabolic dysfunction associated steatotic liver disease (MASLD). Currently …

Methods Based on the Jinchang cohort, 30,633 participants were collected. The prevalence
and incidence of MAFLD and NAFLD were used to analyze the epidemic characteristics and …